Anthem Biosciences' IPO is seeing huge demand on its last day. The issue has been subscribed 1,400% so far, showing strong interest from all types of investors. At the same time, the GMP has jumped to ...

Anthem Biosciences IPO GMP surged on Wednesday as the Rs 3,395-crore initial share saw robust subscription on the concluding day of the public issue. The issue which began on July 14 in the primary ...

Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here ...

Anthem Biosciences is raising ₹3,395 crore through an initial share sale, which comprises of entirely an offer-for-sale by ...

The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non-institutional ...

Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...

The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...

Anthem Biosciences Rs. 3,395 crore IPO fully subscribed on day 2 of offering on July 15: Our Bureau, Bengaluru Wednesday, July 16, 2025, 11:30 Hrs [IST] The initial public offerin ...

Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises in fermentation-based active pharmaceutical ingredients (APIs) for global ...

Anthem Biosciences IPO closes today; check GMP, latest subscription stats, and key dates -act now before bidding ends!